Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 12, 2010, Pages 1805-1812

  Išić, Tijana ^a   Savin, Svetlana ^a   Cvejić, Dubravka ^a   Marečko, Ilona ^a   Tatić, Svetislav ^a   Havelka, Marija ^a   Paunović, Ivan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cyfra 21.1; Cytokeratin 19; Galectin 3; Human serum; Immunohistochemistry; Thyroid carcinoma

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 19 FRAGMENT; GALECTIN 3; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; PATIENT ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TISSUE LEVEL;

ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; KERATIN-19; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649334474     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0838-3     Document Type: Article

References (39)

1. M Appetecchia A Meçule M Ducci L Palma M Castelli 2001 Serum cytokeratins determination in differentiated thyroid carcinoma J Exp Clin Cancer Res 20 253 256 1:STN:280:DC%2BD38%2FislClsA%3D%3D 11484983
2. SL Asa 2005 The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid Endocr Pathol 16 295 309 10.1385/EP:16:4:295 16627917 (Pubitemid 43787106)
3. V Barak H Goike KW Panaretakis R Einarsson 2004 Clinical utility of cytokeratins as tumor markers Clin Biochem 37 529 540 1:CAS:528: DC%2BD2cXltl2gtLc%3D 10.1016/j.clinbiochem.2004.05.009 15234234 (Pubitemid 38845016)
4. SH Barondes DN Cooper MA Gitt H Leffler 1994 Galectins. Structure and function of a large family of animal lectins J Biol Chem 269 20807 20810 1:CAS:528:DyaK2cXlsFWgurc%3D 8063692
5. J Bártek J Bartkova J Taylor-Papadimitriou A Rejthar J Kovarik Z Lukas B Vojtesek 1986 Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies Histochem J 18 565 575 10.1007/BF01675198 2433255
6. A Bartolazzi A Gasbarri M Papotti G Bussolati T Lucante A Khan H Inohara F Marandino F Orlandi F Nardi A Vecchione R Tecce O Larsson ThyroidCancerStudy Group 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions Lancet 357 1644 1650 1:STN:280: DC%2BD3MzmtlGktw%3D%3D 10.1016/S0140-6736(00)04817-0 11425367 (Pubitemid 32568236)
7. MF Beesley KM McLaren 2002 Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules Histopathology 41 236 243 1:STN:280:DC%2BD38vltlGgtg%3D%3D 10.1046/j.1365-2559. 2002.01442.x 12207785 (Pubitemid 35013945)
8. CC Cheung S Ezzat JL Freeman IB Rosen SL Asa 2001 Immunohistochemical diagnosis of papillary thyroid carcinoma Mod Pathol 14 338 342 1:STN:280:DC%2BD3MzisFWjuw%3D%3D 10.1038/modpathol.3880312 11301350 (Pubitemid 32298919)
9. D Cvejic S Savin I Paunovic S Tatic M Havelka J Sinadinovic 1998 Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue Anticancer Res 18 2637 2642 1:CAS:528:DyaK1cXlsF2htrk%3D 9703921
10. D Cvejic S Selemetjev S Savin I Paunovic S Tatic 2009 Changes in the balance between proliferation and apoptosis during the progression of malignancy in thyroid tumours Eur J Histochem 53 65 72 1:STN:280:DC%2BD1MrlvVSrtQ%3D%3D 19683979
11. A Danguy I Camby R Kiss 2002 Galectins and cancer Biochem Biophys Acta 1572 285 293 1:CAS:528:DC%2BD38XmvVagsb8%3D 12223276
12. PL Fernández MJ Merino M Gómez E Campo T Medina V Castronovo X Sanjuán A Cardesa FT Liu ME Sobel 1997 Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue J Pathol 181 80 86 10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E 9072007 (Pubitemid 27099778)
13. A Gadducci M Ferdeghini S Cosio A Fanucchi R Cristofani AR Genazzani 2001 The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer Int J Gynecol Cancer 11 277 282 1:STN:280:DC%2BD3MvotVSitA%3D%3D 10.1046/j.1525-1438.2001.011004277.x 11520365 (Pubitemid 32751395)
14. Y Gao L Hankui Y Zhibin Z Ruisen 2009 Tumor markers in thyroid carcinoma with pulmonary metastases after thyroidectomy Lab Med 40 30 34 10.1309/LM8FZXW08BRJSJSR
15. L Giovanella L Ceriani A Ghelfo M Maffioli 2008 Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland Int J Biol Markers 23 61 64
16. Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. In: International histological classification of tumours. World Health Organization, 2nd edn. Springer, Geneva, pp 1-66
17. H Inohara Y Honjo T Yoshii S Akahani J Yoshida K Hattori S Okamoto T Sawada A Raz T Kubo 1999 Expression of galectin-3 in fine needle aspirates as a differential diagnostic marker between benign and malignant thyroid neoplasms Cancer 85 2475 2484 1:STN:280:DyaK1M3osVeisQ%3D%3D 10.1002/(SICI)1097- 0142(19990601)85:11<2475::AID-CNCR25>3.0.CO;2-1 10357421 (Pubitemid 29244859)
18. H Inohara T Segawa A Miyauchi T Yoshii S Nakahara A Raz M Maeda E Miyoshi N Kinoshita H Yoshida M Furukawa Y Takenaka Y Takamura Y Ito N Taniguchi 2008 Cytoplasmic and serum gal-3 in diagnosis of thyroid malignancies Biochem Biophys Res Commun 376 605 610 1:CAS:528:DC%2BD1cXht1ens77J 10.1016/j.bbrc.2008.09.041 18809382
19. I Iurisci N Tinari C Natoli D Angelucci E Cianchetti S Iacobelli 2000 Concentrations of galectin-3 in the sera of normal controls and cancer patients Clin Cancer Res 6 1389 1393 1:CAS:528:DC%2BD3cXjtVOqt7k%3D 10778968
20. H Leffler 2001 Galectins: structure and function-a synopsis Results Probl Cell Differ 33 57 83 1:STN:280:DC%2BD3M3gtFCqsQ%3D%3D 11190679
21. S Linder 2007 Cytokeratin markers come of age Tumour Biol 28 189 195 1:CAS:528:DC%2BD2sXhtVWjsrrE 10.1159/000107582 17717426 (Pubitemid 47379291)
22. R Moll M Divo L Langbein 2008 The human keratins: biology and pathology Histochem Cell Biol 129 705 733 1:CAS:528:DC%2BD1cXlvFajt78%3D 10.1007/s00418-008-0435-6 18461349
23. B Nakata Y Ogawa T Ishikawa K Ikeda Y Kato H Nishino K Hirakawa 2000 Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma Cancer 89 1285 1290 1:STN:280:DC%2BD3cvltFagtg%3D%3D 10.1002/1097-0142(20000915) 89:6<1285::AID-CNCR13>3.0.CO;2-G 11002224
24. F Orlandi E Saggiorato G Pivano B Puligheddu A Termine S Cappia P De Giuli A Angeli 1998 Galectin-3 is a presurgical marker of human thyroid carcinoma Cancer Res 58 3013 3020
25. NL Perillo ME Marcus LG Baum 1998 Galectins: versatile modulators of cell adhesion, cell proliferation and cell death J Mol Med 76 402 412 1:CAS:528:DyaK1cXjsleku7k%3D 10.1007/s001090050232 9625297 (Pubitemid 28218642)
26. SJ Raphael 2002 The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia Endocr Pathol 13 301 311 10.1385/EP:13:4:301 12665648 (Pubitemid 36237984)
27. J Rosai E Kuhn ML Carcangiu 2006 Pitfalls in thyroid tumor pathology Histopathology 49 107 120 1:STN:280:DC%2BD28vls1Krsg%3D%3D 10.1111/j.1365-2559. 2006.02451.x 16879388 (Pubitemid 44079694)
28. E Saggiorato S Cappia P De Giuli A Mussa G Pancani P Caraci A Angeli F Orlandi 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma J Clin Endocrinol Metab 86 5152 5158 1:CAS:528:DC%2BD3MXos1Kqsr8%3D 10.1210/jc.86.11.5152 11701669 (Pubitemid 33070230)
29. M Sánchez-Carbayo A Espasa V Chinchilla E Herrero J Megías A Mira F Soria 1999 New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer Clin Chem 45 1944 1953 10545064
30. S Saussez D Glinoer G Chantrain F Pattou B Carnaille S André HJ Gabius G Laurent 2008 Serum galectin 1 and galectin 3 levels in benign and malignant nodular thyroid disease Thyroid 18 705 712 1:CAS:528: DC%2BD1cXos1ChsLY%3D 10.1089/thy.2007.0361 18630998 (Pubitemid 352009927)
31. S Savin D Cvejić M Janković 2003 Expression of galectin-1 and galectin-3 in human fetal thyroid gland J Histochem Cytochem 51 479 483 1:CAS:528:DC%2BD3sXivVerurw%3D 12642626
32. S Savin D Cvejic T Isic I Paunovic S Tatic M Havelka 2008 Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation Hum Pathol 39 1656 1663 1:CAS:528: DC%2BD1cXht1Kns7jJ 10.1016/j.humpath.2008.04.006 18657294
33. S Sohoo SA Hoda J Rosai RA DeLellis 2001 Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution Am J Clin Pathol 116 696 702 10.1309/6D9D-7JCM-X4T5-NNJY (Pubitemid 34453210)
34. TT Sreelekha VM Pradeep K Vijayalakshmi A Belthazar VG Chellam MB Nair MR Pillai 2000 In situ apoptosis in the thyroid Thyroid 10 117 122 1:STN:280:DC%2BD3c7otFCktw%3D%3D 10.1089/thy.2000.10.117 10718547
35. S Suzuki H Furukawa A Tsuchiya 1999 Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma Thyroid 9 921 925 1:STN:280:DyaK1Mvlt1ajsA%3D%3D 10.1089/thy.1999.9.921 10524571
36. F Van den Brule S Califice V Castronovo 2004 Expressions of galectins in cancer: a critical review Glycoconj J 19 537 542 10.1023/B:GLYC.0000014083. 48508.6a 14758077
37. F Wu M Nishioka J Fujita M Murota Y Ohtsuki T Ishida S Kuriyama 2002 Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines Int J Oncol 20 31 37 1:CAS:528:DC%2BD38XlvFejtA%3D%3D 11743639
38. XC Xu AK El-Naggar R Lotan 1995 Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications Am J Pathol 147 815 822 1:CAS:528:DyaK2MXoslKjtrk%3D 7677193
39. A Yoshida Y Nakamura T Imada T Asaga A Shimizu M Harada 1999 Apoptosis and proliferative activity in thyroid tumors Surg Today 29 204 208 1:STN:280:DyaK1M3gs12ntA%3D%3D 10.1007/BF02483007 10192728